Predictive Oncology Inc. (POAI)

Market Cap	9.91M
Revenue (ttm)	1.62M
Net Income (ttm)	-12.66M
Shares Out	8.93M
EPS (ttm)	-2.32
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	73,281
Open	1.070
Previous Close	1.070
Day's Range	1.010 - 1.130
52-Week Range	0.550 - 3.060
Beta	1.30
Analysts	Hold
Price Target	n/a
Earnings Date	May 20, 2025

About POAI

Predictive Oncology Inc., a knowledge and science-driven company, applies artificial intelligence (AI) to support the discovery and development of cancer therapies. It operates through two segments, Pittsburgh and Eagan. The Pittsburgh segment provides services that include the application of AI using its proprietary biobank of 150,000+ tumor samples. This segment also creates proprietary 3D culture models used in drug development. The Eagan segment produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid wa...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2002
• Employees: 24
• Stock Exchange: NASDAQ
• Ticker Symbol: POAI
• Website: https://www.predictive-oncology.com

Financial Performance

In 2024, Predictive Oncology's revenue was $1.62 million, a decrease of -0.24% compared to the previous year's $1.63 million. Losses were -$12.66 million, -9.44% less than in 2023.